Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

November 29, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2027

Conditions
Muscle-Invasive Bladder CarcinomaChemotherapy EffectSurgery
Interventions
DRUG

cisplatin based neoadjuvant chemotherapy

cisplatin based neoadjuvant chemotherapy

PROCEDURE

Radical cystectomy alone

RC alone

Trial Locations (1)

00144

Riccardo Mastroianni, Rome

All Listed Sponsors
lead

Regina Elena Cancer Institute

OTHER

NCT05776758 - Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt | Biotech Hunter | Biotech Hunter